Jemperli
NDC 0173-0898, dostarlimab, injection, from GlaxoSmithKline LLC.
- Product NDC
- 0173-0898
- Status
- Listed
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761174
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOSTARLIMAB50 mg/mL
Pharmacologic classes
Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0173-0898-03 | 00173089803 | 1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/095eab9f-545a-4f12-bfb7-19477fb901a5Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0173-0898
Use it
Look up 0173-0898 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0173-0898. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.